Immune mechanisms of oral immunotherapy

Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2018-02, Vol.141 (2), p.491-498
Hauptverfasser: Kulis, Michael D., Patil, Sarita U., Wambre, Erik, Vickery, Brian P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 498
container_issue 2
container_start_page 491
container_title Journal of allergy and clinical immunology
container_volume 141
creator Kulis, Michael D.
Patil, Sarita U.
Wambre, Erik
Vickery, Brian P.
description Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune response, but a detailed synthesis of OIT's mechanisms of action is lacking. In this rostrum we review the current evidence regarding the human immune response to OIT, explore possible mechanisms, and identify knowledge gaps for future research.
doi_str_mv 10.1016/j.jaci.2017.12.979
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6939858</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674917329482</els_id><sourcerecordid>2014367346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-677f3701f5ab6a724359af294019c69b0fa1ceb17311721c3b60bdaa565517753</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMoWh9_wIUUXOimY24ykweIIMUXFNzoOmTSjM3QmdRkpuC_N0OrqAtX4XK_c3LvPQidAs4AA7uqs1oblxEMPAOSSS530Aiw5BMmSLGLRhhLmDCeywN0GGONU02F3EcHRBIhMBcjdPHUNH1rx401C9262MSxr8Y-6OXYDR3fLWzQq49jtFfpZbQn2_cIvd7fvUwfJ7Pnh6fp7WxickG79BmvKMdQFbpkmpOcFlJXROYYpGGyxJUGY0vgFIATMLRkuJxrXbCiAM4LeoRuNr6rvmzs3Ni2S7OoVXCNDh_Ka6d-d1q3UG9-rZikUhQiGVxuDYJ_723sVOOisculbq3vowIpiMiB5jKh53_Q2vehTeupdNOcMk5zliiyoUzwMQZbfQ8DWA05qFoNOQwaroColEMSnf1c41vydfgEXG8Am465djaoaJxtjZ27YE2n5t795_8JRXCYHw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2014367346</pqid></control><display><type>article</type><title>Immune mechanisms of oral immunotherapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kulis, Michael D. ; Patil, Sarita U. ; Wambre, Erik ; Vickery, Brian P.</creator><creatorcontrib>Kulis, Michael D. ; Patil, Sarita U. ; Wambre, Erik ; Vickery, Brian P.</creatorcontrib><description>Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune response, but a detailed synthesis of OIT's mechanisms of action is lacking. In this rostrum we review the current evidence regarding the human immune response to OIT, explore possible mechanisms, and identify knowledge gaps for future research.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2017.12.979</identifier><identifier>PMID: 29288078</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Oral ; Allergens ; Allergens - immunology ; Allergens - therapeutic use ; antibodies ; Antigens ; B cells ; basophils ; Clinical trials ; Desensitization ; Desensitization (Psychology) ; Desensitization, Immunologic - methods ; Food allergies ; Food Hypersensitivity - immunology ; Food Hypersensitivity - pathology ; Food Hypersensitivity - therapy ; Human behavior ; Humans ; immune mechanisms ; Immune response ; Immunoglobulins ; Immunotherapy ; mast cells ; Oral immunotherapy ; Rostrum ; sustained unresponsiveness ; T cells</subject><ispartof>Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.491-498</ispartof><rights>2017 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright © 2017 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Feb 1, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-677f3701f5ab6a724359af294019c69b0fa1ceb17311721c3b60bdaa565517753</citedby><cites>FETCH-LOGICAL-c483t-677f3701f5ab6a724359af294019c69b0fa1ceb17311721c3b60bdaa565517753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2017.12.979$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29288078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kulis, Michael D.</creatorcontrib><creatorcontrib>Patil, Sarita U.</creatorcontrib><creatorcontrib>Wambre, Erik</creatorcontrib><creatorcontrib>Vickery, Brian P.</creatorcontrib><title>Immune mechanisms of oral immunotherapy</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune response, but a detailed synthesis of OIT's mechanisms of action is lacking. In this rostrum we review the current evidence regarding the human immune response to OIT, explore possible mechanisms, and identify knowledge gaps for future research.</description><subject>Administration, Oral</subject><subject>Allergens</subject><subject>Allergens - immunology</subject><subject>Allergens - therapeutic use</subject><subject>antibodies</subject><subject>Antigens</subject><subject>B cells</subject><subject>basophils</subject><subject>Clinical trials</subject><subject>Desensitization</subject><subject>Desensitization (Psychology)</subject><subject>Desensitization, Immunologic - methods</subject><subject>Food allergies</subject><subject>Food Hypersensitivity - immunology</subject><subject>Food Hypersensitivity - pathology</subject><subject>Food Hypersensitivity - therapy</subject><subject>Human behavior</subject><subject>Humans</subject><subject>immune mechanisms</subject><subject>Immune response</subject><subject>Immunoglobulins</subject><subject>Immunotherapy</subject><subject>mast cells</subject><subject>Oral immunotherapy</subject><subject>Rostrum</subject><subject>sustained unresponsiveness</subject><subject>T cells</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtLAzEUhYMoWh9_wIUUXOimY24ykweIIMUXFNzoOmTSjM3QmdRkpuC_N0OrqAtX4XK_c3LvPQidAs4AA7uqs1oblxEMPAOSSS530Aiw5BMmSLGLRhhLmDCeywN0GGONU02F3EcHRBIhMBcjdPHUNH1rx401C9262MSxr8Y-6OXYDR3fLWzQq49jtFfpZbQn2_cIvd7fvUwfJ7Pnh6fp7WxickG79BmvKMdQFbpkmpOcFlJXROYYpGGyxJUGY0vgFIATMLRkuJxrXbCiAM4LeoRuNr6rvmzs3Ni2S7OoVXCNDh_Ka6d-d1q3UG9-rZikUhQiGVxuDYJ_723sVOOisculbq3vowIpiMiB5jKh53_Q2vehTeupdNOcMk5zliiyoUzwMQZbfQ8DWA05qFoNOQwaroColEMSnf1c41vydfgEXG8Am465djaoaJxtjZ27YE2n5t795_8JRXCYHw</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Kulis, Michael D.</creator><creator>Patil, Sarita U.</creator><creator>Wambre, Erik</creator><creator>Vickery, Brian P.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180201</creationdate><title>Immune mechanisms of oral immunotherapy</title><author>Kulis, Michael D. ; Patil, Sarita U. ; Wambre, Erik ; Vickery, Brian P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-677f3701f5ab6a724359af294019c69b0fa1ceb17311721c3b60bdaa565517753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Administration, Oral</topic><topic>Allergens</topic><topic>Allergens - immunology</topic><topic>Allergens - therapeutic use</topic><topic>antibodies</topic><topic>Antigens</topic><topic>B cells</topic><topic>basophils</topic><topic>Clinical trials</topic><topic>Desensitization</topic><topic>Desensitization (Psychology)</topic><topic>Desensitization, Immunologic - methods</topic><topic>Food allergies</topic><topic>Food Hypersensitivity - immunology</topic><topic>Food Hypersensitivity - pathology</topic><topic>Food Hypersensitivity - therapy</topic><topic>Human behavior</topic><topic>Humans</topic><topic>immune mechanisms</topic><topic>Immune response</topic><topic>Immunoglobulins</topic><topic>Immunotherapy</topic><topic>mast cells</topic><topic>Oral immunotherapy</topic><topic>Rostrum</topic><topic>sustained unresponsiveness</topic><topic>T cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulis, Michael D.</creatorcontrib><creatorcontrib>Patil, Sarita U.</creatorcontrib><creatorcontrib>Wambre, Erik</creatorcontrib><creatorcontrib>Vickery, Brian P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulis, Michael D.</au><au>Patil, Sarita U.</au><au>Wambre, Erik</au><au>Vickery, Brian P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune mechanisms of oral immunotherapy</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>141</volume><issue>2</issue><spage>491</spage><epage>498</epage><pages>491-498</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>Oral immunotherapy (OIT) has demonstrated reproducibly successful desensitization in patients with food allergy completing clinical trials and, in some studies, sustained unresponsiveness. These clinical outcomes have been associated with characteristic modifications in the allergen-specific immune response, but a detailed synthesis of OIT's mechanisms of action is lacking. In this rostrum we review the current evidence regarding the human immune response to OIT, explore possible mechanisms, and identify knowledge gaps for future research.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29288078</pmid><doi>10.1016/j.jaci.2017.12.979</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.491-498
issn 0091-6749
1097-6825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6939858
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Administration, Oral
Allergens
Allergens - immunology
Allergens - therapeutic use
antibodies
Antigens
B cells
basophils
Clinical trials
Desensitization
Desensitization (Psychology)
Desensitization, Immunologic - methods
Food allergies
Food Hypersensitivity - immunology
Food Hypersensitivity - pathology
Food Hypersensitivity - therapy
Human behavior
Humans
immune mechanisms
Immune response
Immunoglobulins
Immunotherapy
mast cells
Oral immunotherapy
Rostrum
sustained unresponsiveness
T cells
title Immune mechanisms of oral immunotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A55%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20mechanisms%20of%20oral%20immunotherapy&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Kulis,%20Michael%20D.&rft.date=2018-02-01&rft.volume=141&rft.issue=2&rft.spage=491&rft.epage=498&rft.pages=491-498&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2017.12.979&rft_dat=%3Cproquest_pubme%3E2014367346%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2014367346&rft_id=info:pmid/29288078&rft_els_id=S0091674917329482&rfr_iscdi=true